SCHEMBL22987448

SCHEMBL22987448

C[C@@H](N)C(=O)NC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3562819 1.00
SCHEMBL2156256 1.00
Hydrochloric Acid SCHEMBL22979117 0.98 SMYD3 (0.47)
Hydrochloric Acid SCHEMBL22979118 0.98 SMYD3 (0.47)
SCHEMBL15906217 0.92 EPHX1 (0.50)
SCHEMBL22629584 0.92 EPHX1 (0.50)
SCHEMBL13457996 0.92 EPHX2 (0.54)
SCHEMBL15906216 0.92 EPHX1 (0.50)
SCHEMBL13458124 0.92 EPHX2 (0.54)
SCHEMBL268852 0.91 ATM (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
CN-110511213-B Immunomodulator 成都先导药物开发股份有限公司 2021-10-19 CN disclosed
WO-2021028382-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2021-02-18 WO disclosed
CN-110511213-A A kind of immunomodulator CHENGDU HITGEN DEV CO LTD 2019-11-29 CN disclosed